Fact sheet for patients describing psychosis and schizophrenia, including signs and symptoms and treatment options.

Fact sheet for providers with recommended pharmacologic interventions, ways to manage side effects, and a list of resources.

Enterprise Intelligence and Data Solutions Military Health System Information Platform Data Science Resources

MHS GENESIS data assets can be found in the MHS GENESIS Data Guide.

Intrepid Voices Newsletter, July 2023 is a product of the Defense Intrepid Network for TBI and Brain Injury.

Psych Health Evidence Brief about Cognitive Behavioral Therapy for Major Depressive Disorder. Cognitive behavioral therapy was developed in the 1970s by Aaron T. Beck and is one of the most-researched treatments in psychotherapy. The relationship between the person’s thoughts and how their perception of events influences their behavior is the ...

Psych Health Evidence Brief about Client Centered Therapy for Major Depressive Disorder. Client-centered therapy, also known as person-centered therapy, often referred to as “supportive therapy,” is a non-directive approach underpinning most psychotherapy models originating in humanistic psychology developed by Carl Rogers. In this approach, the ...

Psych Health Evidence Brief about Acceptance Commitment Therapy for Major Depressive Disorder. Acceptance and commitment therapy is considered a “third wave” cognitive behavioral therapy, a new generation of psychological therapies developed to overcome potential limitations of traditional “second wave” CBT treatments (behavioral therapy is ...

Psych Health Evidence Brief about Behavioral Therapy Behavioral Activation for Major Depressive Disorder. Behavioral therapy refers to a class of psychological interventions which improves symptoms and functioning through behavior change by leveraging principles of reinforcement.

Psych Health Evidence Brief about Botulinum Toxin for Major Depressive Disorder. Botulinum toxin is a neurotoxin produced by the bacterium Clostridium botulinum. Glabellar injection (between the eyebrows) of BTX is currently being investigated in Phase Ill clinical trials as a treatment for depression.

Authorship Criteria for Medical Surveillance Monthly Report publication.

ABA Maximum Allowed Rates Effective May 1, 2023

The enclosed template memorandum will be used by OM and other health care providers to provide consistent health communication to all DoD firefighters. This template memorandum provides each firefighter their PF AS blood testing results, the purpose of the PF AS blood testing, interpretation of PF AS blood test results, and sources of additional ...

Traumatic Brain Injury Center of Excellence, Cubist Podcast Transcript: Session 6, Episode 8, Decision-Making Tools for TBI Diagnosis in Austere Environments.

Double sided one page patient handout tool to gather info to share with your provider to accurately diagnose & treat your headache(s).